ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 26273 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 26273; 2) Community: the network communities that were significantly associated with the response to NSC 26273; 3) Molecule: the relationships between components within communities and NSC 26273; 4) MDR: the compounds that were significantly associated with the NSC 26273.

NSC Compound Enrichment Correlation
NSC 265211 NSC 265211 0.00478110474063449 0.18298082
NSC 659609 Null 0.00478110474063449 0.49313139
NSC 668296 Null 0.00478110474063449 0.20040184
NSC 731806 Null 0.00478110474063449 0.32003638
NSC 626673 Null 0.00479683626511385 0.51398334
NSC 628114 9-N(N'-chloroethyl-N'-ethyl-1,2-diaminoethyl) 2-methoxyacridine dihydrochloride 0.00479683626511385 0.55544325
NSC 632620 9-Methoxy-2-[(benzoyloxy)methyl]-5,11-dimethyl- 6H-pyrido[4,3-b]carbazolium iodide 0.00479683626511385 0.44876672
NSC 639503 Cyclopentanone, 2-hexylidene-5-[(4-morpholinyl)methyl]-, hydrochloride 0.00479683626511385 0.35102689
NSC 639504 Cyclopentanone, 2-[(dimethylamino)methyl]-5-octylidene-, hydrochloride 0.00479683626511385 0.37954201
NSC 641297 ANTINEOPLASTIC-641297 0.00479683626511385 0.39753086
Total:101  Current:19    [First] [Prev] [Next] [Last]